[Federal Register Volume 80, Number 105 (Tuesday, June 2, 2015)]
[Notices]
[Pages 31379-31380]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13314]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement, RFA-EH-
15-002, Development and validation of laboratory procedures using next 
generation sequencing technologies to assess genes causing severe 
combined immune deficiency (SCID) in state newborn screening 
laboratories.
    Times and Dates: 11:00 a.m.-3:00 p.m., EDT, June 25, 2015 (CLOSED).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c)(4)

[[Page 31380]]

and (6), Title 5 U.S.C., and the Determination of the Director, 
Management Analysis and Services Office, CDC, pursuant to Public Law 
92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Development and validation of laboratory procedures using next 
generation sequencing technologies to assess genes causing severe 
combined immune deficiency (SCID) in state newborn screening 
laboratories'', EH15-002.
    Contact Person for More Information: Jane Suen, Dr.P.H., M.S., 
Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F63, 
Atlanta, Georgia 30341-3724, Telephone (770) 488-4281.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-13314 Filed 6-1-15; 8:45 am]
 BILLING CODE 4163-18-P